CRL250417P200000
- 0.00
- 0.000.00%
Charles River Newsroom
Baird Adjusts Charles River Laboratories International Price Target to $155 From $173, Maintains Neutral Rating
Goldman Sachs Downgrades Charles River(CRL.US) to Hold Rating, Cuts Target Price to $170
Charles River Analyst Ratings
Charles River Labs (CRL) Was Downgraded to a Hold Rating at Goldman Sachs
Citi Upgrades Charles River(CRL.US) to Hold Rating, Maintains Target Price $175
Charles River Labs Price Target Raised to $175.00/Share From $155.00 by Citigroup
Charles River Labs Raised to Neutral From Sell by Citigroup
Charles River Analyst Ratings
Citi Upgrades Charles River(CRL.US) to Hold Rating, Maintains Target Price $175
Redburn Atlantic Upgrades Charles River(CRL.US) to Hold Rating, Raises Target Price to $188
Evercore Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $175
Charles River Labs (CRL) Gets a Hold From Evercore ISI
TD Cowen Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $179
Charles River Labs Hold Rating: Balancing Strong Financial Performance With Cautious 2025 Outlook
J.P. Morgan Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $165
Stephens Cuts Charles River Laboratories International Price Target to $190 From $240
Charles River Labs Price Target Cut to $165.00/Share From $175.00 by JP Morgan
Charles River Labs Is Maintained at Neutral by JP Morgan
Baird Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $173
Charles River Analyst Ratings